Agreed but it’s other people speculating based on micro cap daily press release on March 25th suggesting this. I am trying to understand the Lewis and Clark merger and how it will help in a buyout. Wondering why they have been inactive for so long on phase 3 with a drug offering such great potential and wondering why these patents have spent so long doing nothing. I do believe they were renewed for a purpose and concluded it was to renewed for a merger or buyout. Could be totally wrong , but I made a decent sized bet here . Thinking phase 3 begins somehow with this once funds come in.
The spike in trading activity can be attributed to one word ADENOSINE! It is what links NSPX to Gileads remdesivir. The company has said nothing concerning COVID-19. The trading activity is the result of trader's imagination that something may develop from that association. In the mean time more eyes see the drugs and pipeline and patents that NSPX owns and this also has helped trading activity. Why would they issue a PR denying something that they never had part in doing?
News 
Market Data 
Discover 
AI
